EANS-DD: Marinomed Biotech AG / Notification concerning transactions by persons performing managerial responsibilities pursuant to article 19 Market Abuse Regulation (MAR)

27.01.2020, 1248 Zeichen
Directors' Dealings-Announcement pursuant to artikle 19 MAR transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement.
personal data:
responsible party:
name: Brigitte EDERER (natural person)
reason:
reason: responsible party is a person with managerial responsibilities function: Member of an administrative or supervisory board
issuer information:
name: Marinomed Biotech AG Legal Entity Identifier (LEI): 529900GN3B1EN80XF405
information about deal:
ISIN: ATMARINOMED6 description of the financial instrument: Share type: acquisition date: 23.01.2020; UTC+01:00 market: Vienna Stock Exchange AG, XWBO currency: Euro
price volume EUR 97 150 shares
total volume: 150 shares total price: EUR 14,550 average price: EUR 97
end of announcement euro adhoc
issuer: Marinomed Biotech AG Veterinärplatz 1 A-1210 Wien phone: 0043250774460 FAX: 0043250774493 mail: office@marinomed.com WWW: www.marinomed.com ISIN: ATMARINOMED6, AT0000A1WD52 indexes: stockmarkets: Wien language: English
Digital press kit: http://www.ots.at/pressemappe/31479/aom

Christian Drastil: Wiener Börse Plausch

Börsepeople im Podcast S12/11: Patrick Kesselhut

Bildnachweis

1. Marinomed - Starke Partner für beschleunigtes Wachstum   >> Öffnen auf photaq.com

Aktien auf dem Radar:Addiko Bank, Immofinanz, Wienerberger, Flughafen Wien, Warimpex, Porr, AT&S, Palfinger, Strabag, Uniqa, Verbund, Pierer Mobility, Andritz, Frequentis, S Immo, Oberbank AG Stamm, Amag, Agrana, CA Immo, Erste Group, EVN, Kapsch TrafficCom, OMV, Österreichische Post, Telekom Austria, VIG, Deutsche Bank, IBM, Caterpillar, Beiersdorf, Symrise.

---

Mehr aktuelle OTS-Meldungen HIER